Headquartered in Switzerland, CARBOGEN AMCIS is a leading provider of drug development and commercialization services to the pharmaceutical and biopharmaceutical industries. The company provides innovative, timely and safe drug development solutions and supports the development process from bench to market. CARBOGEN AMCIS has a breadth of capabilities spanning from contract chemical process research and development to the supply of active pharmaceutical ingredients (APIs) and drug products for preclinical studies, clinical trials and commercial use.